Having begun my professional career at Harvard Medical School in 2015, I have sharpened my scientific repertoire working with some of the leading expert scientists, doctors, pathologists, clinicians, and principal investigators on projects ranging from various cancers to COVID-19 and many maladies in between. With an emphasis on cancer microscopy, I have established myself as one of the leading high-throughput multiplexed imaging microscopists in the field. With over six years of experience with cyclic immunofluorescence (CyCIF), I have recently begun to adapt Codex multiplexed staining and high-throughput imaging using the novel Fusion scanner at BostonGene Corp where I began working in January 2022. With such elevated throughput and plexity, we can characterize, describe, and investigate the tumor microenvironment (TME), cell-to-cell interactions, cluster like and unalike cell populations, spatial relations, and more using leading and advancing technology. It is my responsibility and goal to produce highly actionable data that can elucidate individualized cancer phenotypes and share this information with pathologists and clinicians to help lead to precision medicine. My primary duties at BostonGene are to acquire multiplex images of tumors, profile the results, and improve experimental, imaging, and analytical pipelines through the generation of actionable data. Lauded for my enthusiastic collaborative nature, easy-going personality, and incomparable data collection, I have positioned myself well to continue to share and grow my knowledge as it pertains to oncology, immunology, pathology, and microscopy. Ideally, over the coming years, I will continue to advance myself as a scientist and scientific thinker, share and culture my expertise, and contribute to scientific and medical research that will enhance the lives of many. I have a penchant for learning and a curiosity that cannot be satiated -- I look forward to contributing to and learning from a rapidly growing and evolving field.